CCIN
gene geneOn this page
Also known as KBTBD14BTBD20
Summary
CCIN (calicin, HGNC:1568) is a protein-coding gene on chromosome 9p13.3, encoding Calicin (Q13939). Required for both nuclear and acrosomal shaping during spermiogenesis.
The protein encoded by this gene is a basic protein of the sperm head cytoskeleton. This protein contains kelch repeats and a BTB/POZ domain and is necessary for normal morphology during sperm differentiation. This gene is intronless.
Source: NCBI Gene 881 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 83 total — 5 pathogenic
- Phenotypes (HPO): 8
- MANE Select transcript:
NM_005893
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:1568 |
| Approved symbol | CCIN |
| Name | calicin |
| Location | 9p13.3 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | KBTBD14, BTBD20 |
| Ensembl gene | ENSG00000185972 |
| Ensembl biotype | protein_coding |
| OMIM | 603960 |
| Entrez | 881 |
Gene structure
Transcript identifiers
Ensembl transcripts: 1 — 1 protein_coding
ENST00000335119
RefSeq mRNA: 1 — MANE Select: NM_005893
NM_005893
CCDS: CCDS6599
Canonical transcript exons
ENST00000335119 — 1 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001334442 | 36169388 | 36171334 |
Expression profiles
Bgee: expression breadth ubiquitous, 115 present calls, max score 93.71.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.2055 / max 202.0861, expressed in 4 samples.
FANTOM5 promoters (3 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 96673 | 0.1338 | 4 |
| 96672 | 0.0687 | 3 |
| 96671 | 0.0030 | 2 |
Top tissues by expression
277 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| left testis | UBERON:0004533 | 93.71 | gold quality |
| right testis | UBERON:0004534 | 93.24 | gold quality |
| testis | UBERON:0000473 | 90.94 | gold quality |
| sperm | CL:0000019 | 87.46 | gold quality |
| male germ cell | CL:0000015 | 87.38 | gold quality |
| adult organism | UBERON:0007023 | 86.18 | gold quality |
| endometrium epithelium | UBERON:0004811 | 80.25 | gold quality |
| type B pancreatic cell | CL:0000169 | 78.51 | gold quality |
| olfactory bulb | UBERON:0002264 | 73.68 | gold quality |
| tongue squamous epithelium | UBERON:0006919 | 70.85 | gold quality |
| diaphragm | UBERON:0001103 | 69.65 | gold quality |
| triceps brachii | UBERON:0001509 | 69.32 | gold quality |
| gluteal muscle | UBERON:0002000 | 68.15 | gold quality |
| smooth muscle tissue | UBERON:0001135 | 67.56 | gold quality |
| biceps brachii | UBERON:0001507 | 66.93 | gold quality |
| skeletal muscle tissue of biceps brachii | UBERON:0004502 | 65.32 | gold quality |
| frontal pole | UBERON:0002795 | 64.96 | gold quality |
| paraflocculus | UBERON:0005351 | 64.11 | gold quality |
| middle frontal gyrus | UBERON:0002702 | 63.60 | gold quality |
| cervix epithelium | UBERON:0004801 | 61.70 | gold quality |
| epithelial cell of pancreas | CL:0000083 | 61.43 | gold quality |
| cervix squamous epithelium | UBERON:0006922 | 60.66 | gold quality |
| stromal cell of endometrium | CL:0002255 | 60.60 | gold quality |
| myocardium | UBERON:0002349 | 60.53 | gold quality |
| lateral nuclear group of thalamus | UBERON:0002736 | 60.35 | gold quality |
| upper arm skin | UBERON:0004263 | 60.14 | gold quality |
| skeletal muscle tissue of rectus abdominis | UBERON:0004511 | 59.43 | gold quality |
| Brodmann (1909) area 10 | UBERON:0013541 | 59.11 | gold quality |
| tendon of biceps brachii | UBERON:0008188 | 59.10 | gold quality |
| quadriceps femoris | UBERON:0001377 | 58.38 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 1.63 |
Regulation
Is transcription factor: no
Cross-species orthologs
2 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Ccin | ENSMUSG00000070999 |
| rattus_norvegicus | Ccin | ENSRNOG00000014831 |
Paralogs (54): KLHL13 (ENSG00000003096), KLHL20 (ENSG00000076321), KEAP1 (ENSG00000079999), KLHL42 (ENSG00000087448), KLHL22 (ENSG00000099910), KLHL4 (ENSG00000102271), KLHL2 (ENSG00000109466), KLHL5 (ENSG00000109790), BACH2 (ENSG00000112182), KLHL18 (ENSG00000114648), KLHL24 (ENSG00000114796), IVNS1ABP (ENSG00000116679), KLHL12 (ENSG00000117153), KLHL29 (ENSG00000119771), KBTBD7 (ENSG00000120696), KLHL7 (ENSG00000122550), KLHL31 (ENSG00000124743), KLHDC7B (ENSG00000130487), KLHL36 (ENSG00000135686), KLHL8 (ENSG00000145332), KLHL3 (ENSG00000146021), KLHL35 (ENSG00000149243), KLHL1 (ENSG00000150361), BACH1 (ENSG00000156273), KLHL40 (ENSG00000157119), KLHL10 (ENSG00000161594), KLHL21 (ENSG00000162413), KLHDC8A (ENSG00000162873), KBTBD8 (ENSG00000163376), KBTBD6 (ENSG00000165572), KLHL26 (ENSG00000167487), KLHL30 (ENSG00000168427), KBTBD2 (ENSG00000170852), KLHL6 (ENSG00000172578), KLHL15 (ENSG00000174010), KLHL38 (ENSG00000175946), KBTBD11 (ENSG00000176595), KLHDC7A (ENSG00000179023), KLHL28 (ENSG00000179454), KBTBD3 (ENSG00000182359)
Protein
Protein identifiers
Calicin — Q13939 (reviewed: Q13939)
All UniProt accessions (2): Q13939, Q8WX35
UniProt curated annotations — full annotation on UniProt →
Function. Required for both nuclear and acrosomal shaping during spermiogenesis.
Subunit / interactions. Interacts with CYLC1; the interaction may be relevant for proper acrosome attachment to the nuclear envelope.
Subcellular location. Cytoplasm. Cytoskeleton. Perinuclear theca. Calyx.
Tissue specificity. Expressed in testis, in spermatozoa (at protein level).
Disease relevance. Spermatogenic failure 91 (SPGF91) [MIM:620838] An autosomal recessive, male infertility disorder due to globozoospermia and asthenoteratozoospermia. Patient sperm show defects of the head, including a misshapen rounded head and detachment of the acrosome, and the sperm fail to attach to the zona pellucida of the egg. The disease is caused by variants affecting the gene represented in this entry.
RefSeq proteins (1): NP_005884* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR000210 | BTB/POZ_dom | Domain |
| IPR006652 | Kelch_1 | Repeat |
| IPR011333 | SKP1/BTB/POZ_sf | Homologous_superfamily |
| IPR011705 | BACK | Domain |
| IPR015915 | Kelch-typ_b-propeller | Homologous_superfamily |
| IPR017096 | BTB-kelch_protein | Family |
| IPR048070 | Calicin_BTB_POZ | Domain |
Pfam: PF00651, PF07707, PF13964
UniProt features (19 total): sequence variant 6, repeat 6, sequence conflict 3, domain 2, chain 1, modified residue 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q13939-F1 | 90.53 | 0.72 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Post-translational modifications (1): 149
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 96 (showing top):
GOBP_MACROMOLECULE_CATABOLIC_PROCESS, GOBP_MALE_GAMETE_GENERATION, GGGTGGRR_PAX4_03, MORF_IL4, chr9p13, GNF2_CCNA1, ATF3_Q6, WEBER_METHYLATED_LCP_IN_SPERM_UP, GOBP_DEVELOPMENTAL_PROCESS_INVOLVED_IN_REPRODUCTION, GOBP_PROTEASOMAL_PROTEIN_CATABOLIC_PROCESS, PIT1_Q6, NKX3A_01, GOBP_PROTEIN_CATABOLIC_PROCESS, TGGAAA_NFAT_Q4_01, GOCC_TRANSFERASE_COMPLEX
GO Biological Process (3): spermatogenesis (GO:0007283), cell differentiation (GO:0030154), proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161)
GO Molecular Function (2): ubiquitin-like ligase-substrate adaptor activity (GO:1990756), protein binding (GO:0005515)
GO Cellular Component (5): nucleus (GO:0005634), cytoplasm (GO:0005737), Cul3-RING ubiquitin ligase complex (GO:0031463), cytoskeletal calyx (GO:0033150), cytoskeleton (GO:0005856)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| cellular anatomical structure | 2 |
| developmental process involved in reproduction | 1 |
| male gamete generation | 1 |
| cellular developmental process | 1 |
| ubiquitin-dependent protein catabolic process | 1 |
| proteasomal protein catabolic process | 1 |
| enzyme-substrate adaptor activity | 1 |
| binding | 1 |
| intracellular membrane-bounded organelle | 1 |
| intracellular anatomical structure | 1 |
| cullin-RING ubiquitin ligase complex | 1 |
| perinuclear theca | 1 |
| intracellular membraneless organelle | 1 |
Protein interactions and networks
STRING
308 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| CCIN | CYLC1 | P35663 | 979 |
| CCIN | CYLC2 | Q14093 | 962 |
| CCIN | DPY19L2 | Q6NUT2 | 496 |
| CCIN | ACTRT1 | Q8TDG2 | 482 |
| CCIN | SPATA16 | Q9BXB7 | 451 |
| CCIN | VPS54 | Q9P1Q0 | 447 |
| CCIN | OR1L1 | Q8NH94 | 447 |
| CCIN | GBE1 | Q04446 | 441 |
| CCIN | SPACA1 | Q9HBV2 | 412 |
| CCIN | ACTRT2 | Q8TDY3 | 398 |
| CCIN | OR1J1 | Q8NGS3 | 390 |
| CCIN | ZPBP | Q9BS86 | 377 |
| CCIN | GOPC | Q9HD26 | 377 |
| CCIN | CALML6 | Q8TD86 | 375 |
| CCIN | CALML3 | P27482 | 375 |
IntAct
15 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| PRKN | CCIN | psi-mi:“MI:0915”(physical association) | 0.560 |
| VHL | CCIN | psi-mi:“MI:0915”(physical association) | 0.560 |
| HTT | CCIN | psi-mi:“MI:0915”(physical association) | 0.560 |
| TARDBP | CCIN | psi-mi:“MI:0915”(physical association) | 0.560 |
| CCIN | HSP90AA1 | psi-mi:“MI:0914”(association) | 0.350 |
| CCIN | CCZ1B | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (9): CCIN (Synthetic Lethality), HSP90AB4P (Affinity Capture-MS), HSPA8 (Affinity Capture-MS), HSP90AA1 (Affinity Capture-MS), HSPA1L (Affinity Capture-MS), CCZ1 (Affinity Capture-MS), NUDCD3 (Affinity Capture-MS), CCIN (Cross-Linking-MS (XL-MS)), APP (Reconstituted Complex)
ESM2 similar proteins: A0A1B8YAB1, B1H285, B3DIV9, E9QIN8, E9QJ30, F1QEG2, O88879, Q08CL3, Q08CY1, Q0D2A9, Q13939, Q28068, Q3UQV5, Q3ZCT8, Q503R4, Q5F3N5, Q5R4S6, Q5R663, Q5RG82, Q5XHZ6, Q5XI58, Q5ZI33, Q69ZK5, Q6DFF7, Q6DFU2, Q6Q7X9, Q6V595, Q7ZVQ8, Q86V97, Q8BHI4, Q8BUL5, Q8BWA5, Q8CA72, Q8CDE2, Q8CE33, Q8IXQ5, Q8NAB2, Q8NFY9, Q8R179, Q8WVZ9
Diamond homologs: A0JN76, A1L2U9, A1YPR0, B1WAZ8, B1WBS3, B1WBU4, B2RXF5, E1B932, G5E8B9, G5ED84, O14867, O15062, O15209, O35260, O43298, O88939, O93567, O95365, O95625, P28575, P41182, P41183, P97302, P97303, Q0IH98, Q0IJ29, Q0P4X6, Q0VCJ6, Q13105, Q13939, Q14526, Q1L8W0, Q1LYM6, Q2WGJ6, Q3B7N9, Q3SWU4, Q53G59, Q562B4, Q5R5N5, Q5TC79
SIGNOR signaling
1 interactions.
| A | Effect | B | Mechanism |
|---|---|---|---|
| CCIN | up-regulates | F-actin_assembly |
Disease & clinical
Clinical variants and AI predictions
ClinVar
83 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 5 |
| Likely pathogenic | 0 |
| Uncertain significance | 74 |
| Likely benign | 3 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (5)
| Variant ID | HGVS | Classification |
|---|---|---|
| 1525990 | NM_005893.3(CCIN):c.853G>A (p.Gly285Ser) | Pathogenic |
| 3236746 | NM_005893.3(CCIN):c.125A>T (p.His42Leu) | Pathogenic |
| 3236747 | NM_005893.3(CCIN):c.1294C>T (p.Arg432Trp) | Pathogenic |
| 3236748 | NM_005893.3(CCIN):c.1341C>A (p.Cys447Ter) | Pathogenic |
| 3236749 | NM_005893.3(CCIN):c.230T>C (p.Leu77Pro) | Pathogenic |
SpliceAI
224 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 9:36170806:TGA:T | donor_gain | 0.9600 |
| 9:36170833:T:TA | donor_gain | 0.9600 |
| 9:36170834:A:AA | donor_gain | 0.9600 |
| 9:36170808:AAAG:A | donor_gain | 0.9500 |
| 9:36170774:GCA:G | donor_gain | 0.9100 |
| 9:36170794:G:GT | donor_gain | 0.9000 |
| 9:36170815:A:AG | donor_gain | 0.8600 |
| 9:36170835:G:GG | donor_gain | 0.8600 |
| 9:36170727:A:G | donor_gain | 0.8500 |
| 9:36170813:T:TA | donor_gain | 0.8400 |
| 9:36170616:ACCT:A | donor_gain | 0.8300 |
| 9:36170814:T:A | donor_gain | 0.8300 |
| 9:36170812:GT:G | donor_gain | 0.7900 |
| 9:36170703:G:GT | donor_gain | 0.7800 |
| 9:36170767:G:GT | donor_gain | 0.7700 |
| 9:36170723:A:T | donor_gain | 0.7400 |
| 9:36170827:TCG:T | donor_gain | 0.7300 |
| 9:36170617:C:G | donor_gain | 0.6900 |
| 9:36170816:T:G | donor_gain | 0.6900 |
| 9:36170801:C:CG | donor_gain | 0.6500 |
| 9:36170807:GAA:G | donor_gain | 0.6100 |
| 9:36170775:C:T | donor_gain | 0.6000 |
| 9:36170836:T:TG | donor_gain | 0.5800 |
| 9:36170837:G:GG | donor_gain | 0.5800 |
| 9:36170838:G:GG | donor_gain | 0.5800 |
| 9:36170897:C:CT | acceptor_gain | 0.5400 |
| 9:36170895:TTC:T | acceptor_gain | 0.5200 |
| 9:36170800:GCTT:G | donor_gain | 0.5100 |
| 9:36170722:G:GT | donor_gain | 0.4800 |
| 9:36170832:G:GT | donor_gain | 0.4800 |
AlphaMissense
3896 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 9:36170709:T:A | W403R | 0.998 |
| 9:36170709:T:C | W403R | 0.998 |
| 9:36169568:G:C | R22S | 0.997 |
| 9:36169568:G:T | R22S | 0.997 |
| 9:36170112:T:A | W204R | 0.997 |
| 9:36170112:T:C | W204R | 0.997 |
| 9:36170503:G:A | G334D | 0.997 |
| 9:36170565:T:A | W355R | 0.997 |
| 9:36170565:T:C | W355R | 0.997 |
| 9:36170601:T:C | F367L | 0.997 |
| 9:36170603:C:A | F367L | 0.997 |
| 9:36170603:C:G | F367L | 0.997 |
| 9:36170644:G:A | G381D | 0.997 |
| 9:36170647:G:A | G382E | 0.997 |
| 9:36169567:G:C | R22T | 0.996 |
| 9:36170185:T:A | V228D | 0.996 |
| 9:36170467:C:A | A322D | 0.996 |
| 9:36170500:G:A | G333D | 0.996 |
| 9:36170646:G:T | G382W | 0.996 |
| 9:36170114:G:C | W204C | 0.995 |
| 9:36170114:G:T | W204C | 0.995 |
| 9:36170634:T:G | Y378D | 0.995 |
| 9:36171180:T:A | W560R | 0.995 |
| 9:36171180:T:C | W560R | 0.995 |
| 9:36169862:T:G | C120W | 0.994 |
| 9:36170104:T:C | L201P | 0.994 |
| 9:36170421:T:A | W307R | 0.994 |
| 9:36170421:T:C | W307R | 0.994 |
| 9:36170500:G:T | G333V | 0.994 |
| 9:36170503:G:T | G334V | 0.994 |
dbSNP variants (sampled 300 via entrez): RS1000447808 (9:36168391 T>A,C), RS1000925798 (9:36168074 CTG>C), RS1001105715 (9:36167844 A>G), RS1002663010 (9:36171069 G>A), RS1004669722 (9:36168427 T>C), RS1004882222 (9:36168965 C>A,T), RS1005299297 (9:36168789 T>A), RS1005886106 (9:36167480 C>T), RS1006816052 (9:36171590 C>T), RS1006872459 (9:36171583 T>G), RS1006874881 (9:36171665 C>T), RS1007336903 (9:36171283 G>C,T), RS1007899869 (9:36170046 C>A,T), RS1008943025 (9:36169178 C>A,G,T), RS1009530247 (9:36167811 G>A)
Disease associations
OMIM: gene MIM:603960 | disease phenotypes: MIM:620838
GenCC curated gene-disease
Mondo (1): spermatogenic failure 91 (MONDO:0970952)
Orphanet (0):
HPO phenotypes
8 total (8 of 8 shown, HPO-id order):
| HPO | Term |
|---|---|
| HP:0000007 | Autosomal recessive inheritance |
| HP:0000798 | Oligozoospermia |
| HP:0003251 | Male infertility |
| HP:0011462 | Young adult onset |
| HP:0012205 | Globozoospermia |
| HP:0012207 | Reduced sperm motility |
| HP:0033393 | Irregularly shaped sperm tail |
| HP:0034011 | Reduced progressive sperm motility |
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
5 total (human), top 5 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Glyphosate | decreases expression | 1 |
| Cyclophosphamide | increases expression | 1 |
| Endosulfan | affects cotreatment, decreases expression | 1 |
| Tetrachlorodibenzodioxin | affects cotreatment, decreases expression | 1 |
| Vanadates | increases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
- Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): spermatogenic failure 91